HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ajeesh Koshy Cherian Selected Research

Enzymes

7/2014A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ajeesh Koshy Cherian Research Topics

Disease

2Cognitive Dysfunction
08/2019 - 07/2014
1Brain Concussion (Cerebral Concussion)
08/2019
1Wounds and Injuries (Trauma)
08/2019
1Traumatic Brain Injuries (Traumatic Brain Injury)
08/2019
1Parkinson Disease (Parkinson's Disease)
06/2019
1Movement Disorders (Movement Disorder)
06/2019
1Neuroinflammatory Diseases
09/2017
1Schizophrenia (Dementia Praecox)
07/2014
1Neurobehavioral Manifestations
07/2014

Drug/Important Bio-Agent (IBA)

3Cholinergic Agents (Cholinergics)IBA
08/2019 - 09/2017
1choline transporterIBA
08/2019
1Rivastigmine (Exelon)FDA LinkGeneric
06/2019
1(2- (6- fluoro- 1H- indol- 3- yl)- ethyl)- (3- (2,2,3,3- tetrafluoropropoxy)benzyl)amineIBA
06/2019
1Proteins (Proteins, Gene)FDA Link
09/2017
1KynurenineIBA
07/2014
1PF-04859989IBA
07/2014
1EnzymesIBA
07/2014
1kynurenine-oxoglutarate transaminaseIBA
07/2014
1Glutamic Acid (Glutamate)FDA Link
07/2014